Lumexa Imaging Files 8-K on Financial Results, Reg FD Disclosure
Ticker: LMRI · Form: 8-K · Filed: Mar 26, 2026 · CIK: 0002071288
Complexity: simple
Sentiment: mixed
Topics: earnings, financial-condition, regulation-fd, corporate-filing
TL;DR
**Lumexa Imaging just dropped an 8-K with financial results, so expect market reaction.**
AI Summary
Lumexa Imaging Holdings, Inc. filed an 8-K on March 26, 2026, reporting its results of operations and financial condition under Item 2.02 and making a Regulation FD Disclosure under Item 7.01. This filing indicates the company is providing updated financial information, likely earnings or a significant financial event, which is crucial for investors to understand the company's current performance and future outlook. Investors should pay close attention to the details in the accompanying exhibits to assess the company's financial health and potential impact on stock value.
Why It Matters
This filing signals that Lumexa Imaging Holdings, Inc. has released important financial updates, which could significantly influence investor perception and stock price. Understanding these results is key to evaluating the company's current valuation and future prospects.
Risk Assessment
Risk Level: medium — The risk level is medium because while the filing itself is routine, the financial information it contains could be positive or negative, impacting the stock price significantly.
Analyst Insight
A smart investor would immediately review Exhibit 99.1 of this 8-K filing to understand the specific financial results and disclosures, as these details will drive market reaction and inform investment decisions for Lumexa Imaging Holdings, Inc.
Key Numbers
- 2026-03-26 — Filing Date (The date the 8-K was filed and accepted by the SEC.)
- 13 — Documents (The total number of documents included in the filing.)
- 29255 — Size (Size of the primary 8-K document (d138307d8k.htm) in bytes.)
- 172372 — Size (Size of Exhibit 99.1 (d138307dex991.htm) in bytes, likely containing the detailed financial results.)
Key Players & Entities
- Lumexa Imaging Holdings, Inc. (company) — the filer of the 8-K
- 0002071288 (company) — CIK of Lumexa Imaging Holdings, Inc.
- 2026-03-26 (date) — filing date and period of report
- 0001193125-26-124978 (dollar_amount) — SEC Accession No.
Forward-Looking Statements
- Lumexa Imaging's stock price will react significantly to the financial details in Exhibit 99.1. (Lumexa Imaging Holdings, Inc.) — high confidence, target: 2026-03-27
- Analysts will issue updated ratings or price targets based on the disclosed financial condition. (Lumexa Imaging Holdings, Inc.) — medium confidence, target: 2026-04-10
FAQ
What specific items were reported in this 8-K filing by Lumexa Imaging Holdings, Inc.?
Lumexa Imaging Holdings, Inc. reported under Item 2.02, 'Results of Operations and Financial Condition,' and Item 7.01, 'Regulation FD Disclosure,' on March 26, 2026.
When was this 8-K filing accepted by the SEC?
The 8-K filing by Lumexa Imaging Holdings, Inc. was accepted by the SEC on March 26, 2026, at 06:09:21.
What is the CIK number for Lumexa Imaging Holdings, Inc.?
The CIK number for Lumexa Imaging Holdings, Inc. is 0002071288.
Where is Lumexa Imaging Holdings, Inc.'s business address located?
Lumexa Imaging Holdings, Inc.'s business address is 4200 SIX FORKS ROAD, SUITE 1000, RALEIGH NC 27609.
What type of business does Lumexa Imaging Holdings, Inc. primarily engage in, according to its SIC code?
According to its SIC code 8071, Lumexa Imaging Holdings, Inc. primarily engages in 'Services-Medical Laboratories'.
Filing Stats: 733 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2026-03-26 06:09:21
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share LMRI The Nasdaq
Filing Documents
- d138307d8k.htm (8-K) — 29KB
- d138307dex991.htm (EX-99.1) — 168KB
- g138307g0326074659987.jpg (GRAPHIC) — 4KB
- 0001193125-26-124978.txt ( ) — 336KB
- lmri-20260326.xsd (EX-101.SCH) — 3KB
- lmri-20260326_lab.xml (EX-101.LAB) — 18KB
- lmri-20260326_pre.xml (EX-101.PRE) — 11KB
- d138307d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press Release dated March 26, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LUMEXA IMAGING HOLDINGS, INC. By: /s/ J. Anthony Martin Date: March 26, 2026 Name: J. Anthony Martin Title: Chief Financial Officer